注册 | 登录
点击这里给我发消息
所有产品
  • 所有产品
  • 一抗
  • 裂解液
>   首页   >   产品   >   一抗   >   基因重组   >   Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab)   

Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab)

Recombinant Antibody

     
  • 0 - Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab) APR10091
    Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
  • 0 - Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab) APR10091
    The purity of Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab) is 98.99%, determined by SEC-HPLC.
  • 0 - Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab) APR10091
    Immobilized human CD30 His at 2 ug/mL can bind Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab), EC50=0.006007 ug/mL.
  • 产品详情
  • 实验流程
Product Information
Application
  • Applications Legend:
  • E=ELISA
  • WB=Western Blotting
  • IHC=Immunohistochemistry
  • IHC-P=Immunohistochemistry (Paraffin)
  • IP=Immunoprecipitation
  • IF=Immunofluorescence
  • IC=Immunochemistry
  • ICC=Immunocytochemistry
  • FC=Flow Cytometry
  • DB=Dot Blot
Functional assay, Kinetics (SPR), Kinetics (BLI), FACS, E, FTA
Primary Accession P28908
Reactivity Human
Clonality Monoclonal
Isotype IgG1
Calculated MW 63747 Da
Additional Information
Target/Specificity TNFRSF8 / CD30
Endotoxin < 0.001EU/ µg,determined by LAL method.
Conjugation Unconjugated
Expression system CHO
Format Purified monoclonal antibody supplied in PBS, pH6.0, without preservative.This antibody is purified through a protein A column.

For Research Use Only. Not For Use In Diagnostic Procedures.

Patent Notice: The variable region sequence of this antibody is derived from a published third-party patent. This product is manufactured independently as a Research Use Only (RUO) reagent and is not licensed, sponsored, or endorsed by the patent holder. It is intended solely for research purposes. Customers considering any commercial, diagnostic, or therapeutic use should independently evaluate freedom-to-operate with respect to relevant third-party patents.

Protein Information
Name TNFRSF8 (HGNC:11923)
Function Receptor for TNFSF8/CD30L (PubMed:8391931). May play a role in the regulation of cellular growth and transformation of activated lymphoblasts. Regulates gene expression through activation of NF-kappa- B (PubMed:8999898).
Cellular Location [Isoform 1]: Cell membrane; Single-pass type I membrane protein
Tissue Location [Isoform 2]: Detected in alveolar macrophages (at protein level).
Research Areas
FeedBack

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。

如有疑问,联系:0512-88856768 tech-china@abcepta.com.


我要评价